« Back to Record
Rao, S., Anandappa, G., Capdevila, J., Dahan, L., Evesque, L., Kim, S., Saunders, M. M., Gilbert, D. D., Jensen, L. H., Samalin, E., Spindler, K. L. G. K., Tamberi, S., Demols, A., Guren, M. M., Arnold, D., Fakih, M., Kayyal, T., Cornfeld, M., Tian, C., Catlett, M., Smith, M., & Spano, J. P. (2022). A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202). ESMO Open, 7(4), 100529. doi:10.1016/j.esmoop.2022.100529
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/349700



